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PET-CT imaging in a patient with progressive 
supranuclear palsy
Imagens de PET-CT em um paciente com paralisia supranuclear progressiva
Anderson Benine Belezia1, Victor Hugo Rocha Marussi1, James Yared3, José Luiz Pedroso2, Orlando G. 
Barsottini2, Acary Souza Bulle Oliveira2, Lázaro Luiz Faria do Amaral1
A 67-year-old woman presented with falls, cognitive im-
pairment, mild upgaze palsy and parkinsonism for 3 years. A 
MRI was unremarkable. A PET-CT with fluorodeoxyglucose 
(FDG) disclosed reduced metabolism in thalami, midbrain 
and frontal cortex (Figure 1), suggesting progressive supranu-
clear palsy (PSP). Posterior MRI showed typical features ob-
served in PSP (Figure 2).
PSP is a neurodegenerative disease which affects brainstem 
and basal ganglia1. Early differentiation between PSP and other 
atypical parkinsonism is a challenge1. MRI abnormalities in PSP 
usually appear in advanced stages2. In PSP, PET-CT involves up-
per brainstem, caudate nuclei, insula cortices and frontal cortex3,4. 
Functional imaging, such as PET-CT, may be relevant in early differ-
entiation between Parkinson’s disease and atypical parkinsonism4.
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Figure 1. PET-CT imaging with fluorodeoxyglucose (FDG) of the patient described. Normal metabolism is red, and reduced 
metabolism is green. The image demonstrates reduced metabolism in medial frontal cortex and anterior portion of the cingulate 
gyrus (arrows A), and in upper midbrain (arrow B).
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In the article “PET-CT imaging in a patient with progressive supranuclear palsy” published in the journal Arquivos de 
Neuro-Psiquiatria, 2015;73(4), in the pages 364 and 365.
The Figure 2 was published in place of Figure 1.
The Figure 1 was publised in place of Figure 2.
Figure 2. Sagittal T1 (A) and FLAIR-weighted (B) brain MRI show midbrain atrophy with antero-posterior midline diameter 
reduction and flattening of the superior midbrain (“Pinguin” sign) (arrows). Axial FLAIR sequences show concave lateral margin of 
the tegmentum (“morning glory” sign) (C) and enlarged interpeduncular cistern (D).
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